-
1
-
-
0035876041
-
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
-
Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
-
(2001)
AIDS
, vol.15
, pp. 1181-1183
-
-
Bangsberg, D.R.1
Perry, S.2
Charlebois, E.D.3
-
2
-
-
0036570904
-
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients
-
Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acq Immun Def Synd 2002;30:105-110.
-
(2002)
J Acq Immun Def Synd
, vol.30
, pp. 105-110
-
-
Garcia De Olalla, P.1
Knobel, H.2
Carmona, A.3
Guelar, A.4
Lopez-Colomes, J.L.5
Cayla, J.A.6
-
3
-
-
0037013038
-
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
-
Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002;16:1051-1058.
-
(2002)
AIDS
, vol.16
, pp. 1051-1058
-
-
Hogg, R.S.1
Heath, K.2
Bangsberg, D.3
-
4
-
-
0142017677
-
-
World Health Organization In: World Health Organization, ed. Geneva
-
World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. In: World Health Organization, ed. Geneva, 2003.
-
(2003)
Adherence to Long-Term Therapies: Evidence for Action
-
-
-
5
-
-
33845359660
-
The elusive gold standard. Future perspectives for HIV adherence assessment and intervention
-
Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acq Immun Def Synd 2006;43:S149-S155.
-
(2006)
J Acq Immun Def Synd
, vol.43
, pp. S149-S155
-
-
Chesney, M.A.1
-
6
-
-
34247583029
-
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
-
Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Int Med 2007;146:564-573.
-
(2007)
Ann Int Med
, vol.146
, pp. 564-573
-
-
Nachega, J.B.1
Hislop, M.2
Dowdy, D.W.3
Chaisson, R.E.4
Regensberg, L.5
Maartens, G.6
-
7
-
-
84929343565
-
-
Avoidable Costs in U.S. Healthcare: The 200 Billion Opportunity from Using Medicines More Responsibly. 2013. Parsippany, NJ: IMS Institute for Healthcare Informatics
-
Aitken M, Valkova S. Avoidable Costs in U.S. Healthcare: The 200 Billion Opportunity from Using Medicines More Responsibly. 2013. Parsippany, NJ: IMS Institute for Healthcare Informatics. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII-Responsible-Use- Medicines-2013.pdf
-
-
-
Aitken, M.1
Valkova, S.2
-
8
-
-
34247560160
-
HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%
-
Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acq Immun Def 2007;45:4-8.
-
(2007)
J Acq Immun Def
, vol.45
, pp. 4-8
-
-
Shuter, J.1
Sarlo, J.A.2
Kanmaz, T.J.3
Rode, R.A.4
Zingman, B.S.5
-
9
-
-
33748642352
-
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression
-
Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 939-941
-
-
Bangsberg, D.R.1
-
10
-
-
36048981531
-
Effect of adherence to HAART on viroloaic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-Treated patients
-
Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on viroloaic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-Treated patients. HIV Clin Trials 2007;8:282-292.
-
(2007)
HIV Clin Trials
, vol.8
, pp. 282-292
-
-
Maggiolo, F.1
Airoldi, M.2
Kleinloog, H.D.3
-
11
-
-
33746902816
-
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis
-
Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296:679-690.
-
(2006)
JAMA
, vol.296
, pp. 679-690
-
-
Mills, E.J.1
Nachega, J.B.2
Buchan, I.3
-
12
-
-
84872678512
-
Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV
-
MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav 2013;17:86-93.
-
(2013)
AIDS Behav
, vol.17
, pp. 86-93
-
-
Macdonell, K.1
Naar-King, S.2
Huszti, H.3
Belzer, M.4
-
13
-
-
0037345510
-
Barriers to HAART adherence among human immunodeficiency virus-infected adolescents
-
Murphy DA, Sarr M, Durako SJ, et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med 2003;157:249-255.
-
(2003)
Arch Pediatr Adolesc Med
, vol.157
, pp. 249-255
-
-
Murphy, D.A.1
Sarr, M.2
Durako, S.J.3
-
14
-
-
84860591105
-
Barriers to medication adherence in HIV-infected children and youth based on self-and caregiver report
-
Buchanan AL, Montepiedra G, Sirois PA, et al. Barriers to medication adherence in HIV-infected children and youth based on self-and caregiver report. Pediatrics 2012;129: e1244-e1251.
-
(2012)
Pediatrics
, vol.129
, pp. e1244-e1251
-
-
Buchanan, A.L.1
Montepiedra, G.2
Sirois, P.A.3
-
15
-
-
33845286853
-
Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators
-
Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006;3:e438.
-
(2006)
PLoS Med
, vol.3
, pp. e438
-
-
Mills, E.J.1
Nachega, J.B.2
Bangsberg, D.R.3
-
16
-
-
0347708659
-
Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients
-
Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 2003;15:217-230.
-
(2003)
AIDS Care
, vol.15
, pp. 217-230
-
-
Murphy, D.A.1
Roberts, K.J.2
Hoffman, D.3
Molina, A.4
Lu, M.C.5
-
17
-
-
24644507807
-
A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment
-
Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis 2005;41:875-882.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 875-882
-
-
Andrade, A.S.1
McGruder, H.F.2
Wu, A.W.3
-
18
-
-
33845367426
-
Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial
-
Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acq Immun Def Synd 2006;43:S41-S47.
-
(2006)
J Acq Immun Def Synd
, vol.43
, pp. S41-S47
-
-
Mannheimer, S.B.1
Morse, E.2
Matts, J.P.3
-
19
-
-
0037391696
-
Qualitative and quantitative assessments of HAART adherence of substance-abusing women
-
Powell-Cope GM, White J, Henkelman EJ, Turner BJ. Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care 2003;15: 239-249.
-
(2003)
AIDS Care
, vol.15
, pp. 239-249
-
-
Powell-Cope, G.M.1
White, J.2
Henkelman, E.J.3
Turner, B.J.4
-
20
-
-
0344735833
-
Use of an on-line pager system to increase adherence to antiretroviral medications
-
Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003;15:787-793.
-
(2003)
AIDS Care
, vol.15
, pp. 787-793
-
-
Safren, S.A.1
Hendriksen, E.S.2
Desousa, N.3
Boswell, S.L.4
Mayer, K.H.5
-
21
-
-
0001696152
-
Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
-
Chesney MA, Ickovics JR, Chambers DB, et al. Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000;12:255-266.
-
(2000)
AIDS Care
, vol.12
, pp. 255-266
-
-
Chesney, M.A.1
Ickovics, J.R.2
Chambers, D.B.3
-
22
-
-
70349768299
-
Antiretroviral therapy in acute and recent HIV infection: A prospective multicenter stratified trial of intentionally interrupted treatment
-
Volberding P, Demeter L, Bosch RJ, et al. Antiretroviral therapy in acute and recent HIV infection: A prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 2009;23:1987-1995.
-
(2009)
AIDS
, vol.23
, pp. 1987-1995
-
-
Volberding, P.1
Demeter, L.2
Bosch, R.J.3
-
23
-
-
0035068386
-
ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1
-
Smeaton LM, DeGruttola V, Robbins GK, Shafer RW. ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1. Controlled Clin Trials 2001;22:142-159.
-
(2001)
Controlled Clin Trials
, vol.22
, pp. 142-159
-
-
Smeaton, L.M.1
Degruttola, V.2
Robbins, G.K.3
Shafer, R.W.4
-
24
-
-
0344149561
-
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection
-
Shafer RW, Smeaton LM, Robbins GK, et al. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. New Engl J Med 2003;349:2304-2315.
-
(2003)
New Engl J Med
, vol.349
, pp. 2304-2315
-
-
Shafer, R.W.1
Smeaton, L.M.2
Robbins, G.K.3
-
25
-
-
0141612909
-
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
-
Fischl MA, Ribaudo HJ, Collier AC, et al. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease. J Infect Dis 2003;188:625-634.
-
(2003)
J Infect Dis
, vol.188
, pp. 625-634
-
-
Fischl, M.A.1
Ribaudo, H.J.2
Collier, A.C.3
-
26
-
-
67650470636
-
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients. A randomized trial
-
Gross R, Tierney C, Andrade A, et al. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients. A randomized trial. Arch Intern Med 2009;169:1224-1232.
-
(2009)
Arch Intern Med
, vol.169
, pp. 1224-1232
-
-
Gross, R.1
Tierney, C.2
Andrade, A.3
-
27
-
-
77749329017
-
Comparison of oncedaily versus twice-daily combination antiretroviral therapy in treatment-naive patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-week randomized controlled trial
-
Flexner C, Tierney C, Gross R, et al. Comparison of oncedaily versus twice-daily combination antiretroviral therapy in treatment-naive patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis 2010;50:1041-1052.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 1041-1052
-
-
Flexner, C.1
Tierney, C.2
Gross, R.3
-
28
-
-
9144272257
-
A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir
-
Hammer SM, Bassett R, Squires KE, et al. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther 2003;8:507-518.
-
(2003)
Antivir Ther
, vol.8
, pp. 507-518
-
-
Hammer, S.M.1
Bassett, R.2
Squires, K.E.3
-
29
-
-
78751559513
-
A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen
-
Hammer SM, Ribaudo H, Bassett R, et al. A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV Clin Trials 2010;11:312-324.
-
(2010)
HIV Clin Trials
, vol.11
, pp. 312-324
-
-
Hammer, S.M.1
Ribaudo, H.2
Bassett, R.3
-
30
-
-
0037055027
-
Dual vs single protease inhibitor therapy following antiretroviral treatment failure-A randomized trial
-
Hammer SM, Vaida F, Bennett KK, et al. Dual vs single protease inhibitor therapy following antiretroviral treatment failure-A randomized trial. JAMA 2002;288:169-180.
-
(2002)
JAMA
, vol.288
, pp. 169-180
-
-
Hammer, S.M.1
Vaida, F.2
Bennett, K.K.3
-
31
-
-
0035958764
-
Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
-
Havlir DV, Gilbert PB, Bennett K, et al. Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS 2001;15:1379-1388.
-
(2001)
AIDS
, vol.15
, pp. 1379-1388
-
-
Havlir, D.V.1
Gilbert, P.B.2
Bennett, K.3
-
32
-
-
33846596702
-
Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen
-
Fischl MA, Collier AC, Mukherjee AL, et al. Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. AIDS 2007;21:325-333.
-
(2007)
AIDS
, vol.21
, pp. 325-333
-
-
Fischl, M.A.1
Collier, A.C.2
Mukherjee, A.L.3
-
33
-
-
67149097953
-
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy
-
Eron JJ Jr., Park JG, Haubrich R, et al. Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy. Antimicrob Agents Chemother 2009;53:2335-2341.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2335-2341
-
-
Eron, J.J.1
Park, J.G.2
Haubrich, R.3
-
34
-
-
20144365012
-
Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results
-
Kashuba AD, Tierney C, Downey GF, et al. Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results. AIDS 2005;19:145-152.
-
(2005)
AIDS
, vol.19
, pp. 145-152
-
-
Kashuba, A.D.1
Tierney, C.2
Downey, G.F.3
-
35
-
-
44949247362
-
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV
-
Collier AC, Tierney C, Downey GF, et al. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. HIV Clin Trials 2008;9:91-102.
-
(2008)
HIV Clin Trials
, vol.9
, pp. 91-102
-
-
Collier, A.C.1
Tierney, C.2
Downey, G.F.3
-
36
-
-
38149142836
-
Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084
-
Cohn SE, Umbleja T, Mrus J, Bardeguez AD, Andersen JW, Chesney MA. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care STDs 2008;22:29-40.
-
(2008)
AIDS Patient Care STDs
, vol.22
, pp. 29-40
-
-
Cohn, S.E.1
Umbleja, T.2
Mrus, J.3
Bardeguez, A.D.4
Andersen, J.W.5
Chesney, M.A.6
-
37
-
-
0037090280
-
Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome
-
Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002;34:1129-1136.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 1129-1136
-
-
Cohn, S.E.1
Kammann, E.2
Williams, P.3
Currier, J.S.4
Chesney, M.A.5
-
38
-
-
79956323731
-
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362
-
Cohn SE, Jiang HY, McCutchan JA, et al. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362. AIDS Care 2011;23:775-785.
-
(2011)
AIDS Care
, vol.23
, pp. 775-785
-
-
Cohn, S.E.1
Jiang, H.Y.2
McCutchan, J.A.3
-
39
-
-
0000095552
-
A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
-
White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrics 1980;48:817-838.
-
(1980)
Econometrics
, vol.48
, pp. 817-838
-
-
White, H.1
-
40
-
-
77950527840
-
Using dominance analysis to determine predictor importance in logistic regression
-
Azen R, Traxel NM. Using dominance analysis to determine predictor importance in logistic regression. J Edu Behav Statistics 2009;34:319-347.
-
(2009)
J Edu Behav Statistics
, vol.34
, pp. 319-347
-
-
Azen, R.1
Traxel, N.M.2
-
41
-
-
12044256695
-
Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression
-
Budescu DV. Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression. Psychol Bull 1993;114:542-551.
-
(1993)
Psychol Bull
, vol.114
, pp. 542-551
-
-
Budescu, D.V.1
-
42
-
-
77949399427
-
Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design
-
Laaksonen MA, Harkanen T, Knekt P, Virtala E, Oja H. Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design. Statistics Med 2010;29:860-874.
-
(2010)
Statistics Med
, vol.29
, pp. 860-874
-
-
Laaksonen, M.A.1
Harkanen, T.2
Knekt, P.3
Virtala, E.4
Oja, H.5
-
44
-
-
0027443759
-
Depressive symptoms and Cd4 lymphocyte decline among HIV-infected men
-
Burack JH, BarrettDC, StallRD, ChesneyMA, EkstrandML, Coates TJ. Depressive symptoms and Cd4 lymphocyte decline among HIV-infected men. JAMA 1993;270:2568-2573.
-
(1993)
JAMA
, vol.270
, pp. 2568-2573
-
-
Burack, J.H.1
Barrettdc2
Stallrd3
Chesneyma4
Ekstrandml5
Coates, T.J.6
-
45
-
-
0035925774
-
Mortality, CD4 cell count decline, and depressive symptoms among HIVseropositive women. Longitudinal analysis from the HIV epidemiology research study
-
Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIVseropositive women. Longitudinal analysis from the HIV epidemiology research study. JAMA 2001;285:1466-1474.
-
(2001)
JAMA
, vol.285
, pp. 1466-1474
-
-
Ickovics, J.R.1
Hamburger, M.E.2
Vlahov, D.3
-
46
-
-
0029899542
-
Psychiatric morbidity on entry to an HIV primary care clinic
-
Lyketsos CG, Hutton H, Fishman M, Schwartz J, Treisman GJ. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS 1996;10:1033-1039.
-
(1996)
AIDS
, vol.10
, pp. 1033-1039
-
-
Lyketsos, C.G.1
Hutton, H.2
Fishman, M.3
Schwartz, J.4
Treisman, G.J.5
-
47
-
-
84906842332
-
Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis
-
Langebeek N, Gisolf EH, Reiss P, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Med 2014;12:142.
-
(2014)
BMC Med
, vol.12
, pp. 142
-
-
Langebeek, N.1
Gisolf, E.H.2
Reiss, P.3
-
48
-
-
84876100453
-
Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: A longitudinal electronic monitoring study
-
Gertsch A, Michel O, Locatelli I, et al. Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: A longitudinal electronic monitoring study. AIDS Patient Care STDs 2013;27:208-210.
-
(2013)
AIDS Patient Care STDs
, vol.27
, pp. 208-210
-
-
Gertsch, A.1
Michel, O.2
Locatelli, I.3
-
49
-
-
84885232972
-
Stages of change for adherence to antiretroviral medications
-
Genberg BL, Lee Y, Rogers WH, Willey C, Wilson IB. Stages of change for adherence to antiretroviral medications. AIDS Patient Care STDs 2013;27:567-572.
-
(2013)
AIDS Patient Care STDs
, vol.27
, pp. 567-572
-
-
Genberg, B.L.1
Lee, Y.2
Rogers, W.H.3
Willey, C.4
Wilson, I.B.5
-
50
-
-
84907608856
-
Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain
-
Navarro J, Perez M, Curran A, et al. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain. AIDS Patient Care STDs 2014;28:537-542.
-
(2014)
AIDS Patient Care STDs
, vol.28
, pp. 537-542
-
-
Navarro, J.1
Perez, M.2
Curran, A.3
-
51
-
-
84905255358
-
Efficacy of an evidence-based ARV adherence intervention in China
-
Williams AB, Wang H, Li X, Chen J, Li L, Fennie K. Efficacy of an evidence-based ARV adherence intervention in China. AIDS Patient Care STDs 2014;28:411-417.
-
(2014)
AIDS Patient Care STDs
, vol.28
, pp. 411-417
-
-
Williams, A.B.1
Wang, H.2
Li, X.3
Chen, J.4
Li, L.5
Fennie, K.6
|